Report Detail

Medical Devices & Consumables Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review

  • RnM3611919
  • |
  • 22 July, 2019
  • |
  • Japan
  • |
  • 44 Pages
  • |
  • GlobalData
  • |
  • Medical Devices & Consumables

Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nipro Corp (Nipro) manufactures, develops and markets pharmaceuticals, medical equipment and functional materials (including glass, rubber and plastic). The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type kits among others. It offers contract manufacturing services of injection, oral and external use drug formulations. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has sales offices in North America, South America, Europe, Asia and Africa. Nipro is headquartered in Osaka, Japan.

Nipro Corp Key Recent Developments

Jan 13,2018: Summary of management policy announced by president Yoshihiko Sano of Nipro, delivered at the New Year’s Management Meeting on January 13, 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table of Contents

    Table of Contents

      List of Tables

        List of Figures

          Section 1 - About the Company

            Nipro Corp - Key Facts

              Nipro Corp - Key Employees

                Nipro Corp - Major Products and Services

                  Nipro Corp - History

                    Nipro Corp - Company Statement

                      Nipro Corp - Locations And Subsidiaries

                        Head Office

                          Other Locations & Subsidiaries

                            Joint Venture

                              Section 2 – Company Analysis

                                Company Overview

                                  Nipro Corp - Business Description

                                    Business Segment: Medical Related

                                      Overview

                                        Performance

                                          Business Segment: Other

                                            Overview

                                              Performance

                                                Business Segment: Pharma Packaging

                                                  Overview

                                                    Performance

                                                      Business Segment: Pharmaceutical Related

                                                        Overview

                                                          Performance

                                                            Geographical Segment: America

                                                              Performance

                                                                Geographical Segment: Asia

                                                                  Performance

                                                                    Geographical Segment: Europe

                                                                      Performance

                                                                        Geographical Segment: Japan

                                                                          Performance

                                                                            R&D Overview

                                                                              Nipro Corp - Corporate Strategy

                                                                                Nipro Corp - SWOT Analysis

                                                                                  SWOT Analysis - Overview

                                                                                    Nipro Corp - Strengths

                                                                                      Nipro Corp - Weaknesses

                                                                                        Nipro Corp - Opportunities

                                                                                          Nipro Corp - Threats

                                                                                            Nipro Corp - Key Competitors

                                                                                              Section 3 – Company Financial Ratios

                                                                                                Financial Ratios - Capital Market Ratios

                                                                                                  Financial Ratios - Annual Ratios

                                                                                                    Performance Chart

                                                                                                      Financial Performance

                                                                                                        Financial Ratios - Interim Ratios

                                                                                                          Financial Ratios - Ratio Charts

                                                                                                            Section 4 – Company’s Lifesciences Financial Deals and Alliances

                                                                                                              Nipro Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

                                                                                                                Nipro Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

                                                                                                                  Nipro Corp, Recent Deals Summary

                                                                                                                    Section 5 – Company’s Recent Developments

                                                                                                                      Jan 13, 2018: Summary of management policy announced by president Yoshihiko Sano of Nipro, delivered at the New Year’s Management Meeting on January 13, 2018

                                                                                                                        Section 6 – Appendix

                                                                                                                          Methodology

                                                                                                                            Ratio Definitions

                                                                                                                              About GlobalData

                                                                                                                                Contact Us

                                                                                                                                  Disclaimer

                                                                                                                                  Summary:
                                                                                                                                  Get latest Market Research Reports on Nipro Corp (8086). Industry analysis & Market Report on Nipro Corp (8086) is a syndicated market report, published as Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review. It is complete Research Study and Industry Analysis of Nipro Corp (8086) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                                                  Last updated on

                                                                                                                                  REPORT YOU MIGHT BE INTERESTED

                                                                                                                                  Purchase this Report

                                                                                                                                  $500.00
                                                                                                                                  $1,000.00
                                                                                                                                  $1,500.00
                                                                                                                                  396.00
                                                                                                                                  792.00
                                                                                                                                  1,188.00
                                                                                                                                  462.00
                                                                                                                                  924.00
                                                                                                                                  1,386.00
                                                                                                                                  75,645.00
                                                                                                                                  151,290.00
                                                                                                                                  226,935.00
                                                                                                                                  41,685.00
                                                                                                                                  83,370.00
                                                                                                                                  125,055.00
                                                                                                                                  Credit card Logo

                                                                                                                                  Related Reports


                                                                                                                                  Reason to Buy

                                                                                                                                  Request for Sample of this report